Company Description
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
The company was founded in 2011 and is headquartered in Santa Monica, California.
Country | United States |
Founded | 2011 |
IPO Date | Sep 23, 2020 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 694 |
CEO | Scott Wagner |
Contact Details
Address: 2701 Olympic Boulevard Santa Monica, California 90404 United States | |
Phone | 855 268 2822 |
Website | goodrx.com |
Stock Details
Ticker Symbol | GDRX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $33.00 |
CIK Code | 0001809519 |
CUSIP Number | 38246G108 |
ISIN Number | US38246G1085 |
Employer ID | 47-5104396 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Scott W. Wagner | Interim Chief Executive Officer and Principal Operating Officer |
Trevor Bezdek | Co-founder and Chairman of the Board |
Douglas Joseph Hirsch | Co-founder, Chief Mission Officer and Director |
Karsten Ian Voermann | Chief Financial Officer |
Romin Nabiey | Chief Accounting Officer |
Bansi Nagji | President of Healthcare |
Mike Walsh | President and Executive Vice President of Prescription Marketplace |
Nitin Shingate | Chief Technology Officer |
Aubrey Reynolds | Director of Investor Relations |
Gracye Cheng | General Counsel and Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 18, 2024 | SCHEDULE 13D/A | Filing |
Dec 18, 2024 | SCHEDULE 13D/A | Filing |
Dec 16, 2024 | 8-K | Current Report |
Dec 2, 2024 | 144 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 7, 2024 | 10-Q | Quarterly Report |
Nov 7, 2024 | 8-K | Current Report |
Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |